ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1933–1944 of 2250 project topics
Tumor-Educated Platelet RNA Profiling
Analyzing RNA from tumor-educated platelets using RNA-seq for cancer detection and type classification from blood.
Transcriptomic Biomarker Development Click to view more details →
NanoString nCounter Biomarker Panel Development
Developing and validating NanoString gene expression panels for clinical diagnostics from FFPE and other challenging sample types.
Transcriptomic Biomarker Development Click to view more details →
Spatial Transcriptomics Tissue Biomarker Platform
A commercial SaaS platform that maps gene expression patterns within intact tissue samples to identify location-specific disease biomarkers. This enables precision diagnostics and therapeutic targeting strategies that command premium pricing in oncology and neurodegenerative disease markets.
Transcriptomic Biomarker Development Click to view more details →
Single-Cell RNA Sequencing Biomarker Discovery Service
A specialized bioinformatics service that profiles individual cell transcriptomes to uncover rare cell population biomarkers for disease stratification and drug response prediction. This generates recurring revenue through data analysis contracts with pharma companies developing companion diagnostics.
Transcriptomic Biomarker Development Click to view more details →
Liquid Biopsy Circulating RNA Panel Development Tool
A proprietary software platform that identifies optimal circulating RNA combinations from plasma or serum for non-invasive disease detection and monitoring. This creates addressable market opportunities in early cancer detection, minimal residual disease tracking, and organ transplant rejection prediction.
Transcriptomic Biomarker Development Click to view more details →
Multi-Omics Integration Platform for Transcriptomic Signatures
A next-generation analytics tool that combines transcriptomic data with proteomics, metabolomics, and genomic variants to build predictive biomarker models. This delivers competitive advantage in drug development partnerships and enables higher-confidence biomarker validation for clinical trials.
Transcriptomic Biomarker Development Click to view more details →
Long-Read Sequencing Biomarker Validation and Commercialization
A specialized service leveraging long-read RNA technologies to validate complex transcriptomic biomarkers including isoform variants and fusion transcripts missed by short-read methods. This unlocks new revenue streams through biomarker licensing agreements and enhanced diagnostic panel differentiation.
Transcriptomic Biomarker Development Click to view more details →
AI-Driven Transcriptomic Biomarker Prediction and Patent Generation
An enterprise machine learning platform that autonomously discovers novel gene expression signatures from large transcriptomic datasets and generates patentable biomarker intellectual property. This creates defensible market positions and generates licensing revenue from diagnostic companies and pharmaceutical manufacturers.
Transcriptomic Biomarker Development Click to view more details →
Rare Solid Tumor WGS Characterization Program
Applying WGS for characterizing genomic landscapes of rare solid tumors for identifying actionable alterations and novel therapeutic targets.
Genomics of Rare Tumors Click to view more details →
Undifferentiated Tumor RNA-Seq Diagnosis
Using RNA-seq fusion gene detection for diagnosing undifferentiated tumors through identification of pathognomonic gene rearrangements.
Genomics of Rare Tumors Click to view more details →
Rare Tumor Biobank Genomic Profiling
Systematically profiling genomic and transcriptomic data from rare tumor biobanks for building molecular databases to guide treatment.
Genomics of Rare Tumors Click to view more details →
Pediatric Rare Tumor Genomics Discovery
Applying WGS in pediatric rare tumor cohorts for identifying novel driver genes and fusion events unique to childhood cancers.
Genomics of Rare Tumors Click to view more details →